Cedar Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48
Closed -$4.58K 117
2025
Q4
$4.58K Hold
48
﹤0.01% 196
2025
Q3
$4.69K Hold
48
﹤0.01% 210
2025
Q2
$5.16K Hold
48
﹤0.01% 189
2025
Q1
$4.84K Hold
48
﹤0.01% 157
2024
Q4
$4.29K Hold
48
﹤0.01% 159
2024
Q3
$4.02K Hold
48
﹤0.01% 235
2024
Q2
$3.7K Sell
48
-58
-55% -$4.25K ﹤0.01% 265
2024
Q1
$7.26K Buy
106
+58
+121% +$3.73K ﹤0.01% 269
2023
Q4
$2.77K Hold
48
﹤0.01% 254
2023
Q3
$2.53K Hold
48
﹤0.01% 261
2023
Q2
$2.6K Hold
48
﹤0.01% 271
2023
Q1
$2.4K Hold
48
﹤0.01% 269
2022
Q4
$2.22K Hold
48
﹤0.01% 269
2022
Q3
$2K Sell
48
-48
-50% -$1.93K ﹤0.01% 300
2022
Q2
$4K Hold
96
﹤0.01% 293
2022
Q1
$4K Hold
96
﹤0.01% 326
2021
Q4
$4K Buy
+96
New +$4.03K ﹤0.01% 320

Other funds holding BSX

Cedar Wealth Management's BSX Position: Q1 2026 in Review

Cedar Wealth Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 48 shares — an estimated $4.58K sold.

Cedar Wealth Management first reported a position in BSX in Q4 2021 and held it in 17 quarters. The position peaked at $7.26K in Q1 2024. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Cedar Wealth Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Cedar Wealth Management sold 48 Boston Scientific shares in Q1 2026, an estimated $4.58K.
  • Cedar Wealth Management first reported a position in Boston Scientific in Q4 2021 and held it in 17 quarters.
  • Cedar Wealth Management's Boston Scientific position peaked at $7.26K in Q1 2024.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cedar Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.